What is the Current Share Price of Zenotech Laboratories Ltd?
- Answer Field
 - 
					
Zenotech Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 51.08 as on Nov 03 2025 03:29 PM.
 
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, ZENOTECH LABORATORIES LTD. share price is currently at ₹ 51.1, which is down by ₹ -2.39 from its previous closing. Today, the stock has fluctuated between ₹ 49.50 and ₹ 51.30. Over the past year, ZENOTECH LABORATORIES LTD. has achieved a return of -34.82 %. In the last month alone, the return has been 1.88 %. Read More...
| Particulars | SEP 2025 (Values in Cr) | 
|---|---|
| Revenue | 10.23 | 
| Operating Expense | 10.73 | 
| Net Profit | -0.84 | 
| Net Profit Margin (%) | -8.21 | 
| Earnings Per Share (EPS) | -0.14 | 
| EBITDA | 3.04 | 
| Effective Tax Rate (%) | 165.87 | 
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High | 
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 32.55 | 13.29 | 1.78 | 249.44 | 30.00 / 68.00 | 
| BLISS GVS PHARMA LTD | 156.60 | 15.52 | 1.57 | 1654.47 | 105.05 / 190.65 | 
| CIPLA LTD | 1501.65 | 22.29 | 3.68 | 121298.96 | 1310.05 / 1672.20 | 
| FERMENTA BIOTECH LIMITED | 275.65 | 7.76 | 2.23 | 811.27 | 219.00 / 449.00 | 
| GLAXOSMITHKLINE PHARMA LT | 2624.25 | 46.95 | 22.78 | 44456.38 | 1924.30 / 3515.95 | 
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High | 
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 32.55 | 17.69 | 5.14 | 249.44 | 30.00 / 68.00 | 
| AMRUTAJAN HEALTH LTD | 724.70 | 38.43 | 6.41 | 2095.15 | 548.05 / 829.00 | 
| ASTRAZENECA PHARMA IND LT | 9535.45 | 112.73 | 30.94 | 23838.63 | 6222.35 / 10653.05 | 
| BLISS GVS PHARMA LTD | 156.60 | 23.44 | 1.56 | 1654.47 | 105.05 / 190.65 | 
Choose a Plan That Suits Your Goals and Needs
                        
                        
                        
                        
                        
                        Zenotech Laboratories Limited was initially established as Sunline Technologies Limited in June, 1989 and changed to the present name w.e.f. August 9, 2004. Company is a loan licensing company catering exclusively to Sun Pharmaceutical Industries Limited, Promoter & holding company and they are specialized contract manufacturing services /processing in parenteral depot formulations, ophthalmic, oncology oral & injectables and general injectables. Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology.
During financial year 2004-05, the Hon'ble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s. Zenotech Technologies Limited with effect from November 1st , 2003. The Company had issued 91,82,500 equity shares to erstwhile shareholders of M/s. Zenotech Laboratories Pvt. Ltd. 
M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited were merged with the Company, on May 2, 2006 through Scheme of Amalgamation, effective from October 1, 2005. 15 generic chemical oncology products were launched by the Company in India. Besides, the Company launched its anesthesia range of products during 2006.
In 2005-06, M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited got merged with the Company and the Scheme of Amalgamation became effective from October 1, 2005. 
Consequent to the consummation of the merger of Ranbaxy Laboratories Limited into SPIL on March 24, 2015, SPIL indirectly acquired 46.84 percent of the voting rights held by Ranbaxy in, and control over the Company and became Promoter of the Company along with Daiichi Sankyo Company Limited and resultant, the Open Offer concluded in August 2015.
The Company started production from its newly commissioned Depot Injectable facility in FY 2019-20. It renovated Biotech API manufacturing facility and the same was leased to Sun Pharmaceutical Industries Limited, for their R&D activities effective from July, 2021.
Zenotech Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 51.08 as on Nov 03 2025 03:29 PM.
The market cap of Zenotech Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 311.70 as on Nov 03 2025 03:29 PM.
The 52 Week High and Low of Zenotech Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 90.00 and ₹ 48.00.
The 1 year returns on the stock has been -34.82%.
As on Nov 03 2025 03:29 PM the price-to-earnings (PE) ratio for Zenotech Laboratories Ltd share is 62.20.
As on Nov 03 2025 03:29 PM, the price-to-book (PB) ratio for Zenotech Laboratories Ltd share is 15.75.
You can trade in Zenotech Laboratories Ltd shares with Bajaj Broking by opening a demat account.
To buy Zenotech Laboratories Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Zenotech Laboratories Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found